PMID- 6324996 OWN - NLM STAT- MEDLINE DCOM- 19840601 LR - 20220311 IS - 0008-5472 (Print) IS - 0008-5472 (Linking) VI - 44 IP - 5 DP - 1984 May TI - Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. PG - 2115-21 AB - Highly malignant rabbit tumor (VX-2) was implanted at the periphery of the liver in 63 rabbits. Selective delivery of the anticancer agent copoly(styrenemaleic acid) conjugated to neocarzinostatin (SMANCS), which was dissolved in an oil contrast medium (Lipiodol), was performed by injection via the proper hepatic artery. The anticancer effect was also evaluated by various parameters. By using low-kVp X-ray examination of the resected rabbit liver, Lipiodol was found to distribute throughout the entire liver arterial lumina and was retained there for about 24 hr, but disappeared from the normal liver arterial lumina gradually. However, Lipiodol was retained in the tumor tissue and vessels for at least 7 days, whereas it was undetectable in any other organs. A radioactive analogue of Lipiodol, a chloroiodinated fatty acid, was prepared by using [14C]linoleic acid. This analogue was used in the study of the distribution by low-kVp X-ray examination, Sudan III staining, and autoradiography. Lipiodol remained in the tumor vessels as well as the tumor cells. The use of the radioisotope yielded a quantitative profile of Lipiodol accumulation in tumor tissues; approximately 1000 times more at 15 min and 100 times more at 3 days after the injection than that of most other organs or plasma. Its major excretion route appeared to be through the bile and then the feces. The biological activity of SMANCS was also determined and was found to be significant in both tumor and liver even 7 days after injection. No activity was found in any other organ or tissue. The relatively high biological activity of SMANCS in the nontumorous liver adjacent to the tumor may be the result of continuous drug release from SMANCS-Lipiodol in the tumor tissue. By histological examination, massive tumor necrosis and infiltration of the inflammatory cells were found in the rabbits treated with SMANCS-Lipiodol. In the rabbits treated with Lipiodol alone, necrosis of the tumor was only minimal, and no infiltration of inflammatory cells was observed. Survival periods of the treated rabbits (n = 14) were significantly longer than those of controls (n = 10); 23.1 +/- 5.5 (S.D.) days versus 16.1 +/- 2.9 days (p less than 0.005), respectively, even though only one injection was used for this highly malignant tumor. Mean tumor size for both groups at laparotomy was 163.3 +/- 83.0 sq mm and 160.5 +/- 76.5 sq mm, respectively (not significant).(ABSTRACT TRUNCATED AT 400 WORDS) FAU - Iwai, K AU - Iwai K FAU - Maeda, H AU - Maeda H FAU - Konno, T AU - Konno T LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Cancer Res JT - Cancer research JID - 2984705R RN - 0 (Antibiotics, Antineoplastic) RN - 0 (Carbon Radioisotopes) RN - 0 (Furans) RN - 0 (Maleic Anhydrides) RN - 0 (Polystyrenes) RN - 0 (poly(maleic acid-styrene)neocarzinostatin) RN - 8001-40-9 (Iodized Oil) RN - 9014-02-2 (Zinostatin) SB - IM MH - Animals MH - Antibiotics, Antineoplastic/*administration & dosage MH - Autoradiography MH - Carbon Radioisotopes MH - Furans/*administration & dosage MH - Iodized Oil/*administration & dosage/metabolism MH - Kinetics MH - Liver/drug effects/pathology MH - Maleic Anhydrides/*administration & dosage/therapeutic use MH - Neoplasms, Experimental/diagnostic imaging/*drug therapy MH - Polystyrenes/*administration & dosage/therapeutic use MH - Rabbits MH - Radionuclide Imaging MH - Tissue Distribution MH - Zinostatin/*administration & dosage/analogs & derivatives/therapeutic use EDAT- 1984/05/01 00:00 MHDA- 1984/05/01 00:01 CRDT- 1984/05/01 00:00 PHST- 1984/05/01 00:00 [pubmed] PHST- 1984/05/01 00:01 [medline] PHST- 1984/05/01 00:00 [entrez] PST - ppublish SO - Cancer Res. 1984 May;44(5):2115-21.